These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 8631022)

  • 21. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.
    Zhang W; Grasso L; McClain CD; Gambel AM; Cha Y; Travali S; Deisseroth AB; Mercer WE
    Cancer Res; 1995 Feb; 55(3):668-74. PubMed ID: 7834638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines.
    Li CY; Nagasawa H; Dahlberg WK; Little JB
    Oncogene; 1995 Nov; 11(9):1885-92. PubMed ID: 7478618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cell cycle regulator genes in KB, a human squamous cell carcinoma cell line, after irradiation.
    Uno M; Otsuki T; Hiratsuka J; Yoden E; Aihara T; Harada T; Imajo Y
    Int J Oncol; 2000 Nov; 17(5):947-54. PubMed ID: 11029497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
    Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
    Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1.
    Vairapandi M; Balliet AG; Fornace AJ; Hoffman B; Liebermann DA
    Oncogene; 1996 Jun; 12(12):2579-94. PubMed ID: 8700517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
    Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
    Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.
    Gorospe M; Cirielli C; Wang X; Seth P; Capogrossi MC; Holbrook NJ
    Oncogene; 1997 Feb; 14(8):929-35. PubMed ID: 9050992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.
    Gudas JM; Nguyen H; Li T; Sadzewicz L; Robey R; Wosikowski K; Cowan KH
    Carcinogenesis; 1996 Jul; 17(7):1417-27. PubMed ID: 8706243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
    Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM
    Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
    DeHaan RD; Yazlovitskaya EM; Persons DL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genes.
    Vikhanskaya F; D'Incalci M; Broggini M
    Int J Cancer; 1995 May; 61(3):397-401. PubMed ID: 7729953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A DNA damage signal is required for p53 to activate gadd45.
    Xiao G; Chicas A; Olivier M; Taya Y; Tyagi S; Kramer FR; Bargonetti J
    Cancer Res; 2000 Mar; 60(6):1711-9. PubMed ID: 10749144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth factor modulation of p53-mediated growth arrest versus apoptosis.
    Canman CE; Gilmer TM; Coutts SB; Kastan MB
    Genes Dev; 1995 Mar; 9(5):600-11. PubMed ID: 7698649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.